SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

12 May 2023 Evaluate
The Total revenue for the quarter ended March 2023 of  Rs. 3742.70 millions remain, more or less, the same.The Net proft of the company remain more or less same to Rs. 400.00  millions from Rs. 448.80 millions ,decline by -10.87%.The company reported a good operating profit of 768.00 millions compared to 707.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 3742.70 3647.00 2.62 15112.50 9410.20 60.60 15112.50 9410.20 60.60
Other Income 0.00 25.10 -100.00 12.80 25.10 -49.00 12.80 25.10 -49.00
PBIDT 768.00 707.20 8.60 3096.20 1822.90 69.85 3096.20 1822.90 69.85
Interest 58.00 44.00 31.82 204.90 113.40 80.69 204.90 113.40 80.69
PBDT 710.00 663.20 7.06 2891.30 1709.50 69.13 2891.30 1709.50 69.13
Depreciation 142.50 124.40 14.55 557.70 372.30 49.80 557.70 372.30 49.80
PBT 567.50 538.80 5.33 2333.60 1337.20 74.51 2333.60 1337.20 74.51
TAX 167.50 90.00 86.11 616.30 270.00 128.26 616.30 270.00 128.26
Deferred Tax 27.50 15.00 83.33 95.00 45.00 111.11 95.00 45.00 111.11
PAT 400.00 448.80 -10.87 1717.30 1067.20 60.92 1717.30 1067.20 60.92
Equity 453.10 455.60 -0.55 453.10 455.60 -0.55 453.10 455.60 -0.55
PBIDTM(%) 20.52 19.39 5.82 20.49 19.37 5.76 20.49 19.37 5.76

Aarti Pharmalabs Share Price

687.25 -0.90 (-0.13%)
24-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.50
Dr. Reddys Lab 1312.40
Cipla 1295.00
Zydus Lifesciences 930.00
Lupin 2285.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×